- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02996175
Treatment of Sleep Disturbances in School-age Children With Down Syndrome
Study Overview
Status
Conditions
Detailed Description
The investigators long-term goal is to improve outcomes for children with DS and their caregivers. Towards that goal, the investigators propose a randomized clinical trial of a behavioral sleep treatment designed specifically for children with DS, documenting the impact not only on sleep, but also on the child's daytime inhibitory control and behavior problems, and the caregiver's sleep and stress levels. The investigators will randomize 80 families of children with DS ages 6-17 to receive either a 5-session behavioral sleep treatment (BST; targeting sleep education, behavioral principles and visual supports) or a general-education control condition (CON). The BST will catered to the unique needs of children with DS, adapting an intervention developed by a member of the investigators research team with NIH support (R34 MH082882) that successfully treats behavioral sleep disturbances in children with autism41. Pre- and post-intervention, children will undergo comprehensive assessments of cognitive, behavioral, and adaptive functioning involving direct testing and input from parents and teachers. Child and parent sleep will be monitored via actigraphy and parent-completed sleep diaries, and parents will report on their stress levels and mood. As a critical first step towards an effective treatment, this initial efficacy study will address 3 aims:
Aim #1: Test the efficacy of manualized BST for improving the sleep of children with DS.
Hypothesis 1: Sleep duration and quality will improve more in the BST condition than the CON condition.
Aim #2: Test the impact of the BST on the daytime functioning of children with DS.
Hypothesis 2: Children receiving BST will make greater gains in inhibitory control, general behavior problems and other measures of executive dysfunction than in the CON condition.
Aim #3: Test whether the BST, which focuses on the child's sleep, also impacts caregivers' sleep and stress.
Hypothesis 3: Parents of children receiving BST will have improved sleep duration and decreased stress.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of Down Syndrome
- 6-17 years of age
- behavioral sleep problem (presence of 5 or more nights a week of: bedtime resistance, delayed sleep onset, problematic sleep associations, nighttime awakenings or morning awakenings)
- English as primary language
Exclusion Criteria:
- past diagnosis of Pervasive Developmental Disorder-Not Otherwise Specified/Autism Spectrum Disorder
- History of blindness,deafness,motor impairment
- nonverbal mental age below 36 months
- any medication change w/in past 2 months affecting sleep
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SMART
Treatment group targeting behavioral sleep problems for 5 weeks.
|
|
ACTIVE_COMPARATOR: WISE
Standard of care sleep treatment enhanced with psychoeducation. 1 Introduction to the general-education program, build rapport with family, and review basic information on Down syndrome 2 Introduction to understanding and interpreting results from clinical evaluations 3 Introduction to educational planning, expectations, and transition planning 4 Introduction to lifespan development and advocacy and support services available 5 Feedback on current concerns and methods for obtaining services to manage concerns
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Longer child sleep duration as measured by actigraphy and Improved sleep quality for child measure by Children's Sleep Habits Questionnaire (CSHQ)
Time Frame: Baseline, 6 Weeks, 19 Weeks
|
33-item Parent reported sleep quality for Child over past week. Each item is scored 1-3 (1 = Rarely, 0-1x/week; 2 = Sometimes, 2-4x/week; 3= Usually, 5-7x/week). There are 6 questions with reverse scoring. This will yield a total between 33 and 99. This will be acquired from parent three times throughout study, data scored and entered into SPSS by coordinator using total score data for comparatives to actigraph results for total sleep. |
Baseline, 6 Weeks, 19 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Improved child behaviors as measured by parent report on Child Behavior Checklist (CBCL)
Time Frame: Baseline, 6 Weeks, 19 Weeks
|
113-Item parent report measure for child behavior now.
Each item is scored 0-2 (0 = Not True (as far as you know); 1 = Somewhat or Sometimes True; 2 = Very True or Often True.
Scoring is done through software giving T-scores for 8 subscales with borderline and clinical ranges identified.
SPSS will be used for analysis to compare to parent report data from a daily behavior journal.
|
Baseline, 6 Weeks, 19 Weeks
|
Longer Parent sleep duration as measured by actigraphy and reduced parental stress as measured by the Family Impact Questionnaire (FIQ).
Time Frame: Baseline, 6 Weeks, 19 Weeks
|
50-item parent report measure rating child's impact on family and different areas of family functioning.
Each of the first 48 items are scored 1-4 (1 = Not at all; 2 = Somewhat; 3 = Much; 4 = Very Much) and items 48 & 49 scored 1-7 (1 = Much Easier; 2 = Easier; 3 = Slightly Easier; 4 = About the Same; 5 = Slightly More Difficult; 6 = More Difficult; 7 = Much More Difficult).
There are 5 items that are reverse scored.
Scoring yields T-scores for 7 subscales.Data will be entered into SPSS and used as a parental stress scale for social impact.
|
Baseline, 6 Weeks, 19 Weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Sleep Wake Disorders
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Abnormalities, Multiple
- Chromosome Disorders
- Syndrome
- Dyssomnias
- Parasomnias
- Down Syndrome
Other Study ID Numbers
- 1R21HD082307-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
-
Cairo UniversityCompleted
-
Institute of Child HealthCompleted
-
Vanderbilt University Medical CenterNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingSpeech Intelligibility Intervention in Down SyndromeUnited States
-
Marmara UniversityCompletedStair up and Down, Amputation | Amputation,Stair up and DownTurkey
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyeloid Proliferations Associated With Down SyndromeUnited States, Canada, Australia, Puerto Rico
-
Eastern Mediterranean UniversityCompletedDown Syndrome, Trisomy 21Cyprus
-
Institut Jerome LejeuneFondation Jérôme LejeuneCompletedDown Syndrome With and Without Auto Immune AbnormalitiesFrance
Clinical Trials on Behavioral Sleep Treatment
-
Beth Israel Deaconess Medical CenterCompletedIrritable Bowel Syndrome | Sleep DisturbanceUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingInsomnia | Crohn DiseaseUnited States
-
University of Missouri-ColumbiaNational Institute of Nursing Research (NINR); University of FloridaRecruitingInsomnia | Chronic Widespread Pain | FibromyalgiaUnited States
-
Psicofundación: Fundación Española para Promoción...Ministry of Health, SpainCompletedMood Disorders | Anxiety Disorders | Somatization Disorder | Pain DisorderSpain
-
University of South FloridaNational Institute on Aging (NIA)CompletedCaregivers of Persons With DementiaUnited States
-
Wayne State UniversityCompletedStress, Emotional | Sleep DisturbanceUnited States
-
Shanghai Jiao Tong University School of MedicineUnknownInfant Sleep ProblemChina
-
University of California, Los AngelesNational Institute on Aging (NIA)Completed
-
Shanghai Jiao Tong University School of MedicineNot yet recruitingInfant Sleep ProblemChina
-
University of BernUniversity Hospital for Child and Adolescent Psychiatry and Psychotherapy...Completed